Patient Advocacy Leadership in Advancing Clinical Recommendations in Ultra-Rare Disease: The CLN1 Batten Disease Experience

被引：0
|
作者：
King, S.
Frazier, M.
机构：
来源：
ANNALS OF NEUROLOGY | 2019年 / 86卷
关键词：
Rare Diseases;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
215
引用
收藏
页码：S139 / S139
页数：1
相关论文
共 35 条
  • [1] Developing treatments for rare diseases on a shoestring: The Batten disease (CLN1) enzyme replacement therapy experience
    Puhl, Ana C.
    Hupcey, Maggie
    Ekins, Sean
    MOLECULAR GENETICS AND METABOLISM, 2023, 138 (02) : 107 - 108
  • [2] Repurposing drugs for CLN1 Batten disease: An integrative drug discovery approach
    Puhl, Ana C.
    Vignaux, Patricia A.
    Minerali, Eni
    Klein, Jennifer J.
    Havener, Tammy M.
    Anderson, Edward
    Hickey, Anthony J.
    Ekins, Sean
    MOLECULAR GENETICS AND METABOLISM, 2021, 132 (02) : S88 - S89
  • [3] Management of CLN1 Disease: International Clinical Consensus
    Augustine, Erika F.
    Adams, Heather R.
    de los Reyes, Emily
    Drago, Kristen
    Frazier, Margie
    Guelbert, Norberto
    Laine, Minna
    Levin, Tanya
    Mink, Jonathan W.
    Nickel, Miriam
    Peifer, Danielle
    Schulz, Angela
    Simonati, Alessandro
    Topcu, Meral
    Turunen, Joni A.
    Williams, Ruth
    Wirrell, Elaine C.
    King, Sharon
    PEDIATRIC NEUROLOGY, 2021, 120 : 38 - 51
  • [4] Development of NtBuHA as a small molecule therapeutic for CLN1 Batten disease: An update on research efforts
    Johansson, Rachel
    Fyke, Zachary A.
    MOLECULAR GENETICS AND METABOLISM, 2023, 138 (02) : 68 - 68
  • [5] AAV-Mediated PPT1 Replacement and Cross Correction for Treating CLN1 Batten Disease
    Alam, Suhail
    Khatiwada, Apeksha
    Cohen, Daniel M.
    Peterson, Drew R.
    White, John
    Derby, Melissa
    Wang, Bo
    Nayal, Mohamad
    Becker, Mallory
    Benakanakere, Manju
    Beck, Heena
    Li, Charlie
    Gentzel, Renee
    McBride, Jodi L.
    Biferi, Maria Grazia
    Ramsburg, Elizabeth
    MOLECULAR THERAPY, 2024, 32 (04) : 735 - 735
  • [6] The patient experience of CHAPLE disease: results from interviews conducted as part of a clinical trial for an ultra-rare condition
    Litcher-Kelly, Leighann
    Ozen, Ahmet
    Ollis, Sarah
    Feldman, Hagit Baris
    Yaworsky, Andrew
    Medrano, Paolo
    Chongsrisawat, Voranush
    Perlee, Lorah
    Walker, Marisa
    Pradeep, Sharanya
    Turner-Bowker, Diane M.
    Kurolap, Alina
    Adiv, Orly Eshach
    Lenardo, Michael J.
    Harari, Olivier A.
    Jalbert, Jessica J.
    ORPHANET JOURNAL OF RARE DISEASES, 2025, 20 (01)
  • [7] Identification of New Modulators and Inhibitors of Palmitoyl-Protein Thioesterase 1 for CLN1 Batten Disease and Cancer
    Puhl, Ana C.
    Raman, Renuka
    Havener, Tammy M.
    Minerali, Eni
    Hickey, Anthony J.
    Ekins, Sean
    ACS OMEGA, 2024, 9 (10): : 11870 - 11882
  • [8] Integrated Applied Clinical Pharmacology in the Advancement of Rare and Ultra-Rare Disease Therapeutics
    Ryder, Steven
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 116 (06) : 1485 - 1495
  • [9] Gaucher disease type 3c: Expanding the clinical spectrum of an ultra-rare disease
    Wang, John S.
    Koch, Rebecca L.
    Kenney-Jung, Daniel
    Huggins, Erin
    Sodhi, Sirajbir S.
    Landstrom, Andrew P.
    Grewal, Dilraj S.
    Kishnani, Priya S.
    JIMD REPORTS, 2024, 65 (05): : 313 - 322
  • [10] Gene-disease relationship evidence: A clinical perspective focusing on ultra-rare diseases
    Santen, Gijs W. E.
    Leitch, Harry G.
    Cobben, Jan
    HUMAN MUTATION, 2022, 43 (08) : 1082 - 1088
1234